Resgen Ltd
Resgen Ltd (RESGEN) last reported results for the quarter ended Mar 2026, with sales of ₹33 crore and net profit of ₹6 crore. The stock last traded at ₹45.2, a market capitalisation of ₹94.9 crore, on a P/E of 9.30. Over the past 52 weeks the stock has ranged between ₹41 and ₹88. Figures are as of 6 Oct 2026 and are not real time.
Resgen Ltd share price and key metrics
- Current price
- ₹45.2
- Market cap
- ₹94.9 cr
- Stock P/E
- 9.30
- Book value
- ₹32.3
- ROE
- 16.3%
- ROCE
- 19.3%
- Dividend yield
- 0.00%
- 52w high / low
- 88.0/41.0
Metrics as of 6 Oct 2026. Not real time.
Track Resgen Ltd
Cruxal reads every Resgen Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Resgen Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- 9%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- 28%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- -17%
- 1 Year
- -47%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- Last Year
- 16%
Resgen Ltd quarterly results
| ₹ crore | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|
| Sales | 39 | 38 | 33 |
| Expenses | 31 | 31 | 26 |
| Operating profit | 8 | 7 | 7 |
| OPM % | 20% | 18% | 20% |
| Other income | 0 | 0 | 2 |
| Interest | 0 | 0 | 0 |
| Depreciation | 2 | 1 | 1 |
| Profit before tax | 6 | 5 | 7 |
| Tax % | 31% | 22% | 32% |
| Net profit | 4 | 4 | 6 |
| EPS (₹) | 1.97 | 1.92 | 2.94 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Resgen Ltd annual results
| ₹ crore | Mar 2025 | Mar 2026 |
|---|---|---|
| Sales | 65 | 71 |
| Operating profit | 15 | 14 |
| OPM % | 24% | 20% |
| Net profit | 8 | 10 |
| EPS (₹) | 3.80 | 4.86 |
TTM is the trailing twelve months to the most recent quarter.
Resgen Ltd balance sheet
| ₹ crore | Mar 2025 | Mar 2026 |
|---|---|---|
| Equity capital | 21 | 21 |
| Reserves | 37 | 47 |
| Borrowings | 5 | 1 |
| Other liabilities | 8 | 6 |
| Total liabilities | 71 | 75 |
| Fixed assets | 17 | 15 |
| CWIP | 0 | 0 |
| Investments | 0 | 5 |
| Other assets | 54 | 55 |
| Total assets | 71 | 75 |
As reported by the company. Total assets equal total liabilities by construction.
Resgen Ltd cash flow
| ₹ crore | Mar 2025 | Mar 2026 |
|---|---|---|
| Cash from operations | 7 | 4 |
| Cash from investing | -1 | -0 |
| Cash from financing | -5 | -3 |
| Net cash flow | 2 | 0 |
| Free cash flow | 6 | 4 |
| CFO / operating profit | 70% | 56% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Resgen Ltd operating ratios
| Per year | Mar 2025 | Mar 2026 |
|---|---|---|
| ROCE % | — | 19% |
| Debtor days | 111 | 129 |
| Inventory days | 181 | 160 |
| Days payable | 22 | 15 |
| Cash conversion cycle | 270 | 274 |
| Working capital days | 198 | 221 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Resgen Ltd shareholding pattern
Promoters held 66.98% at Jun 2026, broadly unchanged since Jun 2025. DIIs 0.00%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 66.05% | 66.05% | 66.52% | 66.52% | 66.80% | 66.80% | 66.98% | 66.98% |
| DIIs | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.00% | 0.00% |
| Public | 33.93% | 33.93% | 33.46% | 33.45% | 33.18% | 33.17% | 33.01% | 33.02% |
| No. of shareholders | 1,722 | 2,141 | 2,182 | 2,286 | 2,288 | 2,224 | 2,076 | 2,054 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Resgen Ltd corporate filings
- Resgen Limited Successfully Passes Both Resolutions at 8th AGM with 100% Approval via Remote E-votingAGM/EGMhigh impact
Cruxal's analysis: Resgen Limited reported a clean slate at its 8th AGM held on 30th September 2026, with…
Read the full analysis - Resgen Limited holds 8th AGM; no new financial disclosures or strategic updates providedAGM/EGMlow impact
Cruxal's analysis: Resgen Limited conducted its 8th Annual General Meeting on 30th September 2026 via video…
Read the full analysis - The trading Window for dealing in securities of the Company will be closed from 01st October, 2026 till 48 hours after the approval of Unaudited Standalone and Consolidated Financial Results ....Insider Trading / SASTlow impact
- Resgen Ltd announces 8th Annual General MeetingCompany Updatelow impact
Cruxal's analysis: Resgen Ltd has published a newspaper advertisement regarding the notice of its 8th Annual…
Read the full analysis - Resgen Ltd schedules 8th Annual General Meeting for September 30, 2026Corp. Actionlow impact
Cruxal's analysis: Resgen Ltd has announced the closure of its Register of Members from September 24, 2026…
Read the full analysis - ResGen Limited Announces 8th Annual General Meeting Scheduled for 30th September 2026AGM/EGMlow impact
Cruxal's analysis: ResGen Limited has issued the formal notice for its 8th Annual General Meeting (AGM) to…
Read the full analysis - Resgen Ltd submits Annual Report for FY 2025-26 and Notice of 8th Annual General MeetingOtherslow impact
Cruxal's analysis: Resgen Ltd has filed its Annual Report for the financial year 2025-26 along with the…
Read the full analysis - ResGen Limited Announces 8th Annual General Meeting Scheduled for 30th September 2026Board Meetinglow impact
Cruxal's analysis: ResGen Limited has formally announced the convening of its 8th Annual General Meeting…
Read the full analysis - Resgen Limited schedules Board Meeting for 8th Annual General Meeting preparationsBoard Meetinglow impact
Cruxal's analysis: Resgen Limited has issued an intimation regarding a Board Meeting scheduled for 8th…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.